Table 2.
Sample | MN | N 1 | N 2 | N p | AB | MNr0 | CBPI |
---|---|---|---|---|---|---|---|
Negative control | |||||||
01 | 7 | 954 | 22 | 24 | 3 | 0.3181 | 1.070 |
02 | 5 | 963 | 19 | 18 | 3 | 0.2631 | 1.055 |
03 | 6 | 949 | 22 | 29 | 0 | 0.2727 | 1.051 |
04 | 3 | 953 | 17 | 30 | 1 | 0.1764 | 1.077 |
05 | 7 | 960 | 22 | 18 | 5 | 0.3181 | 1.058 |
Total | 28 | 4,779 | 102 | 119 | 12 | ||
| |||||||
Positive control (cyclophosphamide) | |||||||
01 | 32 | 906 | 51 | 43 | 6 | 0.6274 | 1.137 |
02 | 31 | 873 | 62 | 65 | 8 | 0.5000 | 1.192 |
03 | 48 | 890 | 70 | 40 | 7 | 0.6857 | 1.150 |
04 | 54 | 903 | 62 | 35 | 14 | 0.8709 | 1.132 |
05 | 50 | 875 | 52 | 73 | 4 | 0.9615 | 1.198 |
Total | 215 | 4,447 | 297 | 256 | 39 | ||
| |||||||
BPV-1 E6 recombinant oncoprotein | |||||||
01 | 51 | 892 | 60 | 48 | 4 | 0.8500 | 1.156 |
02 | 50 | 894 | 74 | 32 | 9 | 0.6756 | 1.138 |
03 | 49 | 900 | 53 | 47 | 10 | 0.9245 | 1.147 |
04 | 40 | 901 | 41 | 58 | 10 | 0.9756 | 1.157 |
05 | 38 | 905 | 43 | 52 | 10 | 0.7307 | 1.147 |
Total | 228 | 4,492 | 271 | 237 | 43 |